The DiFeo lab is a well-integrated research program with a rich repository of patient-derived mouse ovarian and endometrial cancer models that are highly useful for translational research and is perfectly poised to perform impactful research to detect these cancers earlier and treat them more effectively.

 

The work performed in our laboratory spans the continuum of translational research starting with an in-depth analysis of patient samples to functional assessment of key genetic drivers of ovarian cancer progression to the development of a novel early detection biomarkers and therapeutic approaches to abrogate these drivers in order to improve ovarian cancer patient survival.